Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research
Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Bruker Corp. on Track for Longest Winning Streak Since March 2009 -- Data Talk
Express News | Bruker Corp has postponed the sale of the CityPoint office building in London.
Here's Why Bruker (NASDAQ:BRKR) Has A Meaningful Debt Burden
Is Bruker Corporation (BRKR) Among the Best Nanotechnology Stocks to Buy According to Hedge Funds?
Investors in Bruker (NASDAQ:BRKR) Have Unfortunately Lost 27% Over the Last Three Years
Express News | The governor of New York requests an investigation into the death of a Black inmate.
S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead
Express News | USA Food and Drug Administration: Recently recalled organic eggs have a high risk of salmonella contamination.
Bruker to Seek Injunction, Appeal After Court Sides With 10x Genomics in Patent Dispute
Bruker Plans to File for a Stay of NanoString GeoMX Injunction Ruling
Express News | Bruker Corp: Expect to Promptly Seek a Stay of Any Injunction That Is Finally Ordered
Express News | Bruker Corp: Disagree With District Court's Decision to Grant Injunction With Respect to Sales of Geomx Products to New Customers in United States
Bruker Comments on Delaware District Court's Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products
10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US
10x Genomics: Injunction Expected to Prohibit Bruker From Making, Using, Selling or Offering to Sell in U.S. GeoMx Digital Spatial Profiler and Associated Instruments, Reagents and Services for RNA and Protein Detection >BRKR
Reported Earlier, Delaware Jury Awards 10x Genomics $31.7M In Patent Case Against NanoString; Permanent Injunction On GeoMx Takes Effect January 10, 2025, With Royalties For Existing Installations; Additional Rulings On CosMx Expected Spring 2025
Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs
Guggenheim Initiates Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $72
Unlock the Full List